Who Are We?

Luzitin, S.A. is a pharmaceutical company focused on the pursuit of innovative solutions for photodynamic therapy (PDT) and photodiagnosis (PDD).

Our Mission and Strategy

Our mission is to investigate and develop innovative photosensitizing compounds to be used in Photodynamic Therapy (PDT) or Photodynamic Diagnosis (PDD) of cancer and other diseases, thus contributing to human wellness.

We have reached proof-of-concept clinical trials (phase I/II) with our new therapeutic solutions and we are seeking a strategic alliance with third parties for further development.

Luzitin offers access to a game changing and highly efficacious new molecular entity which will bring photodynamic therapy (PDT) into routine daily practice for the targeted therapy of solid tumors.